Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for BioRestorative Therapies (BRTX) over the last 10 years, with Q3 2025 value amounting to $607470.0.

  • BioRestorative Therapies' Other Accumulated Expenses changed N/A to $607470.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $607470.0, marking a year-over-year change of. This contributed to the annual value of $744485.0 for FY2024, which is N/A changed from last year.
  • BioRestorative Therapies' Other Accumulated Expenses amounted to $607470.0 in Q3 2025.
  • Over the past 5 years, BioRestorative Therapies' Other Accumulated Expenses peaked at $744485.0 during Q4 2024, and registered a low of $277610.0 during Q1 2025.